chautauqua clinical research LLC

3715 pleasant avenue
bemus point, new york 14712

NYS Entity Status
ACTIVE

NYS Filing Date
OCTOBER 02, 2014

NYS DOS ID#
4645045

County
CHAUTAUQUA

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - CHAUTAUQUA CLINICAL RESEARCH LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Studies Posted On ClinicalTrials.gov Are Not Government-Approved Or Screened
    By Laura Northrup - Thursday Jul 20, 2017

    When facing an illness, you might turn to a clinical trial for treatment that isn’t available eleswhere. The best place for patients to find trials is the site ClinicalTrials.gov, which is a site administered by the National Institutes of Health and is exactly what it sounds like. The site has trials where researchers are testing experimental drugs or procedures that …

    Source: The Consumerist
  • At ClinicalTrials.Gov, Untested Stem Cell Clinics Advertise for Free!
    By Megan Molteni - Wednesday Jul 19, 2017

    Researchers believe the ballooning stem cell clinic industry is taking advantage of the federal repository's honor system. And patients will be the ones to pay, literally.

    Source: Webmonkey
  • Shareholders Demand More Drastic Shifts at Nestlé
    By STEPHANIE STROM - Tuesday Jun 27, 2017

    The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.

    Source: NYT > Home Page
  • Jihad at Chautauqua
    Thursday Aug 17, 2017

    Shadi Hamid is a moderate, unweaponed jihadi, hoping to conquer by message, to convince his conditioned audience that his culture is superior. 

    Source: American Thinker
  • Third Point, a Hedge Fund, Sets Its Activist Sights on Nestlé
    By MICHAEL J. de la MERCED - Sunday Jun 25, 2017

    The fund, run by Daniel S. Loeb, has called on the Swiss food giant to sell its stake in L’Oréal and move more quickly to adapt to changing consumer tastes.

    Source: NYT > Home Page
  • TNT Research Yields Exciting Results for Future Clinical Applications
    Friday Aug 18, 2017

    Additional information regarding cellular reprogramming utilizing the innovative tissue nano-transfection technology (TNT).

    Source: The Doctor's Channel
chautauqua clinical research llc bemus point ny